Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/15425
Title: | Ethical and legal aspects of oncogenomics | Authors: | Stankov, Karmen Drašković, Dragan Mikov, Momir |
Issue Date: | 1-Apr-2012 | Journal: | Journal of B.U.ON. | Abstract: | The discovery of the genes and cellular pathways that play fundamental roles in several diseases, and the understanding of many diseases at a molecular level due to the advances in the field of genomics, have revolutionized the diagnosis, therapy and prevention of human diseases. Application of genetic testing in numerous medical fields, including pharmacogenomics and oncogenomics, raised numerous ethical questions and introduced legal instruments that are aimed at ensuring the appropriate protection of human research participants. For the effective development of human genomics and translation of novel, validated biomarkers into potentially useful clinical applications in personalized medicine, there is a need for clear ethical standards and principles in all phases of clinical research. © 2012 Zerbinis Medical Publications. | URI: | https://open.uns.ac.rs/handle/123456789/15425 | ISSN: | 11070625 |
Appears in Collections: | MDF Publikacije/Publications |
Show full item record
SCOPUSTM
Citations
2
checked on Nov 20, 2023
Page view(s)
30
Last Week
14
14
Last month
2
2
checked on May 10, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.